SureNano Closes Financing
Rhea-AI Summary
SureNano Science (OTCQB:SURNF) has completed a private placement financing, raising $245,000 through the issuance of 2,450,000 common shares at $0.10 per share. The financing includes $85,000 in debt conversion and $160,000 in cash proceeds.
Company President Charles Malette participated significantly, investing $110,000 in cash and converting $85,000 in debt. Following the transaction, Malette will own 9,621,600 shares, representing 40% ownership of the company. The funds will be used for operating expenses and working capital.
Positive
- Successful completion of $245,000 financing
- Strong insider participation with President investing $195,000 total
- Reduction of $85,000 in company debt through conversion
- Funds secured for operating expenses and working capital
Negative
- Significant share dilution at $0.10 per share
- Increased insider control with President now owning 40% of shares
- Small financing amount may indicate limited investor interest
News Market Reaction – SURNF
On the day this news was published, SURNF gained 598.56%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Vancouver, British Columbia--(Newsfile Corp. - September 19, 2025) - SURENANO SCIENCE LTD. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") announces that it has closed a private placement financing of 2,450,000 common shares at a price of
The Company intends to use the cash proceeds for operating expenses, including legal and audit fees and general working capital. No part of the proceeds will be used in connection with investor relations activities. All securities issued in the private placement will be subject to a four month and a day hold period.
A related party, Charles Malette, participated in the private placement, purchasing shares for
About SureNano Science Ltd.:
The business of SureNano Science Ltd. is the sale and distribution of the SureNano™ surfactant, which is a ready-to-mix food grade compound that provides the base for high performance nanoemulsions to create incredibly homogeneous and stable products while maximizing bioavailability, clarity, and taste. The Company has an exclusive license to distribute the SureNanoTM surfactant within Canada; Oklahoma, USA; and Colorado, USA.
ON BEHALF OF SURENANO SCIENCE LTD.
"Charles MaLette"
CEO, President, Director & Secretary
T: 604-428-5171
E: info@surenano.com
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of SureNano. Forward-looking information is based on certain key expectations and assumptions made by the management of SureNano. In some cases, you can identify forward-looking statements by the use of words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Although SureNano believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because SureNano can give no assurance that they will prove to be correct.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/267243